FTC Says 3rd Circ. Ruling Can't Help AbbVie In AndroGel Case
The Federal Trade Commission has urged the Third Circuit to ignore AbbVie Inc.'s assertion that a recent ruling involving alleged abuse of the litigation process supports the company's bid to evade...To view the full article, register now.
Already a subscriber? Click here to view full article